SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-18-002490
Filing Date
2018-05-15
Accepted
2018-05-15 15:24:26
Documents
70
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q curr_10q.htm 10-Q 330403
2 CERTIFICATION curr_ex311.htm EX-31.1 8836
3 CERTIFICATION curr_ex312.htm EX-31.2 9344
4 CERTIFICATION curr_ex321.htm EX-32.1 3519
5 CERTIFICATION curr_ex322.htm EX-32.2 3421
  Complete submission text file 0001477932-18-002490.txt   3243145

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT curr-20180331.xml EX-101.INS 624055
7 XBRL TAXONOMY EXTENSION SCHEMA curr-20180331.xsd EX-101.SCH 49384
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE curr-20180331_cal.xml EX-101.CAL 43218
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE curr-20180331_def.xml EX-101.DEF 144640
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE curr-20180331_lab.xml EX-101.LAB 260665
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE curr-20180331_pre.xml EX-101.PRE 240225
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55908 | Film No.: 18835843
SIC: 2673 Plastics, Foil & Coated Paper Bags